Eterna Therapeutics
ERNA
#11171
Rank
HK$18.04 M
Marketcap
HK$10.66
Share price
-16.56%
Change (1 day)
1.47%
Change (1 year)

Earnings for Eterna Therapeutics (ERNA)

Earnings in 2026 (TTM): -HK$0.13 Billion

According to Eterna Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -HK$0.12 Billion, an increase over its 2024 earnings that were of -HK$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eterna Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.13 Billion16.71%
2025 -HK$0.12 Billion-62.78%
2024 -HK$0.3 Billion84.63%
2023 -HK$0.17 Billion-16.24%
2022 -HK$0.2 Billion-80.08%
2021 -HK$0.97 Billion1596.7%
2020 -HK$56.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
HK$61.04 B-47,243.04%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-HK$1.47 Billion 1,031.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
HK$0.12 B-196.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$0.15 Billion 15.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-HK$30.3 Million-76.61%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
HK$9.59 B-7,509.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
HK$1.96 B-1,615.19%๐Ÿ‡บ๐Ÿ‡ธ USA